Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

68Ga-FAPI PET visualize heart failure: from mechanism to clinic
Wenyu Song, Xiao Zhang, Shukun He, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 2, pp. 475-485
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Radiopharmaceuticals and their applications in medicine
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
Peng Hou, Haiming Chen, Sung‐Tzu Liang, et al.
Journal of Nuclear Medicine (2025) Vol. 66, Iss. 1, pp. 98-103
Closed Access | Times Cited: 1
Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy
Frank M. Bengel, Johanna Diekmann, Annika Hess, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. Supplement 2, pp. 49S-58S
Open Access | Times Cited: 18
Visualization of fibroblast activation using 68Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
Jana Kupusović, Lukas Kessler, Florian Bruns, et al.
Journal of Nuclear Cardiology (2023) Vol. 30, Iss. 5, pp. 2018-2028
Open Access | Times Cited: 17
From FDG and beyond: the evolving potential of nuclear medicine
Kenji Hirata, Koji Kamagata, Daiju Ueda, et al.
Annals of Nuclear Medicine (2023) Vol. 37, Iss. 11, pp. 583-595
Closed Access | Times Cited: 14
A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement
Weiwei Zhang, Yang Che, Xiaoqiang Tang, et al.
Life Medicine (2023) Vol. 2, Iss. 5
Open Access | Times Cited: 14
Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging
Zhuxin Wei, Hongchuang Xu, Bi-Xi Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2204-2215
Closed Access | Times Cited: 6
The Potential of Fibroblast Activation Protein-Targeted Imaging as a Biomarker of Cardiac Remodeling and Injury
Maday Fernández‐Mayola, James T. Thackeray
Current Cardiology Reports (2023) Vol. 25, Iss. 6, pp. 515-523
Open Access | Times Cited: 13
Cardiovascular PET imaging of fibroblast activation A review of the current literature
Krithika Loganath, Neil J Craig, Anna Barton, et al.
Journal of Nuclear Cardiology (2024), pp. 102106-102106
Open Access | Times Cited: 4
Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [18F]AlF-NOTA-FAPI-04 PET/CT Imaging
Fangfang Sun, Chengdong Wang, Hongbo Feng, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 5, pp. 2634-2641
Open Access | Times Cited: 10
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. Supplement 2, pp. 29S-38S
Open Access | Times Cited: 10
Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease
Matthieu Bailly, A.C. Dupont, Guillaume Domain, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 387-387
Open Access
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
William Serumula, Venesen Pillay, Bawinile Hadebe, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 522-522
Open Access
Cardiac Applications of Fibroblast Activation Protein Imaging
Johanna Diekmann, Frank M. Bengel
PET Clinics (2023) Vol. 18, Iss. 3, pp. 389-396
Closed Access | Times Cited: 9
Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling
Xuzhe Zhang, Qin-Lin Li, Tingting Tang, et al.
JACC Basic to Translational Science (2024) Vol. 10, Iss. 1, pp. 113-127
Open Access | Times Cited: 3
Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application
Gregorio Tersalvi, Vittorio Beltrani, Martin Grübler, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 5, pp. 220-220
Open Access | Times Cited: 7
Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases
Yan Cui, Yuxiang Wang, Shu Wang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6033-6033
Open Access | Times Cited: 6
Sophocarpine Alleviates Isoproterenol-Induced Kidney Injury by Suppressing Inflammation, Apoptosis, Oxidative Stress and Fibrosis
Wei Zhou, Yang Fu, Jinsong Xu
Molecules (2022) Vol. 27, Iss. 22, pp. 7868-7868
Open Access | Times Cited: 8
Tales from the future—nuclear cardio-oncology, from prediction to diagnosis and monitoring
Nidaa Mikaïl, Renata Chequer, Alessio Imperiale, et al.
European Heart Journal - Cardiovascular Imaging (2023) Vol. 24, Iss. 9, pp. 1129-1145
Open Access | Times Cited: 4
Imaging of Cardiac Fibrosis: How Far Have We Moved From Extracellular to Cellular?
Tuğçe Telli, Atefeh Hosseini, Stephan Settelmeier, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 5, pp. 686-700
Open Access | Times Cited: 1
Multi-modality deep learning-based [68Ga]Ga-DOTA-FAPI-04 PET polar map generation: potential value in detecting reactive fibrosis after myocardial infarction
Xiaoya Qiao, Hanzhong Wang, Hongping Meng, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3944-3959
Closed Access | Times Cited: 1
Evaluation of Fibroblast Activation Protein Expression Using68Ga-FAPI46 PET in Hypertension-Induced Tissue Changes
Jung Woo Byun, Jin Chul Paeng, Young Ju Kim, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.267489-jnumed.124.267489
Closed Access | Times Cited: 1
Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure
John Gehris, Charlie Ervin, Charlotte Hawkins, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115914-115914
Open Access | Times Cited: 3
Tumor microenvironment and fibroblast activation protein inhibitor (FAPI) PET: developments toward brain imaging
Mehdi Djekidel, Rahaf Alsadi, Maya Abi Akl, et al.
Frontiers in Nuclear Medicine (2023) Vol. 3
Open Access | Times Cited: 2
Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induced kidney injury
Ahlam M. Alhusaini, Samiyah Alshehri, Wedad S. Sarawi, et al.
Saudi Pharmaceutical Journal (2023) Vol. 32, Iss. 1, pp. 101907-101907
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top